# Arcus Biosciences, Inc.: Form 8-K, filed Aug 27, 2024

- Company: [Arcus Biosciences, Inc.](/companies/rcus.md) (CIK 1724521)
- Form: 8-K
- Filed: 2024-08-27
- Accepted by EDGAR: Aug 27, 2024, 16:12 ET
- Period: 2024-08-27
- Accession: 0001724521-24-000144
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1724521/000172452124000144/rcus-20240827.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1724521/000172452124000144/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1724521/000172452124000144/rcus-20240827.htm

Filed Aug 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001724521-24-000144. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
